BridgeMD
New treatment option for Overweight and/or Obesity
Official title Family-Based Nutrition Intervention to Prevent Overweight and Obesity in School-Age Children.
ClinicalTrials.gov ID: NCT07159971
What this study is testing
- What it's testing
- This proposal aims to enhance the well being of schoolchildren and their families through a mobile application and multidisciplinary intervention model grounded in authoritative parenting principles and social cognitive theory.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 9. Healthy volunteers may be eligible.
You may be able to join if
- Families of children between 5 and 9 years old.
- Children without any medical or nutritional treatment for obesity.
- Children classified as normal weight, overweight, or obese based on WHO (Z-score: height for age and BMI for age).
- Offspring of mothers aged between 18 and 45 years at delivery.
- Term infants from normoevolutive pregnancies without maternal comorbidities.
You likely can't join if
- Children who are currently suffering from a pathology that requires medication or special treatment
- Mothers/Fathers/Guardians who are currently suffering from a pathology that requires medication or special treatment.
- Children who have a physical/mental impairment to perform physical activities.
- Children from surrogate mothers who have presented at least 2 of the 11 DSM-5 criteria for substance use disorder (alcohol, tobacco, cannabis, or...
- Children from multiple pregnancies.
- Parents who do not own a smartphone compatible with the app will be excluded from this study (i.e., version 5.0 or higher for Android).
See the full eligibility criteria
- Families of children between 5 and 9 years old.
- Children without any medical or nutritional treatment for obesity.
- Children classified as normal weight, overweight, or obese based on WHO (Z-score: height for age and BMI for age).
- Offspring of mothers aged between 18 and 45 years at delivery.
- Term infants from normoevolutive pregnancies without maternal comorbidities.
- Families who have a cell phone with internet access and an installed camera.
- Children who are currently suffering from a pathology that requires medication or special treatment
- Mothers/Fathers/Guardians who are currently suffering from a pathology that requires medication or special treatment.
- Children who have a physical/mental impairment to perform physical activities.
- Children from surrogate mothers who have presented at least 2 of the 11 DSM-5 criteria for substance use disorder (alcohol, tobacco, cannabis, or other illegal drugs) before or during the participating child's gestation.
- Children from multiple pregnancies.
- Parents who do not own a smartphone compatible with the app will be excluded from this study (i.e., version 5.0 or higher for Android).
The study team makes the final eligibility decision.
Where it's taking place
- México, Sonora, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 9 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include México, Sonora, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.